Volume 8, Issue 3, September 2020, Page: 94-101
Role of P53 p.Arg72Pro Variant in Recurrent Pregnancy Loss, Recurrent Implantation Failure and IVF Outcome
Navneet Kaur, Department of Reproductive Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom
Mohamed Eltom, Department of Reproductive Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom
Karen Cheung, Department of Reproductive Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom
Siddharth Banka, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom
Lamiya Mohiyiddeen, Department of Reproductive Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom
Received: Jun. 17, 2020;       Accepted: Jul. 27, 2020;       Published: Sep. 8, 2020
DOI: 10.11648/j.ijgg.20200803.11      View  76      Downloads  37
Abstract
The role of p53 p.Arg72Pro variant in recurrent pregnancy loss, recurrent implantation failure and IVF outcome is controversial and research so far has yielded inconsistent results. This systematic review aims to summarise the literature on the role of TP53 p.Arg72Pro variant in recurrent pregnancy loss following natural and assisted conception. A comprehensive literature search was conducted on MEDLINE, EMBASE and CENTRAL electronic databases for literature published between 1998 and April 2020. Inclusion and exclusion criteria and search terms were established. References of retrieved articles were hand searched to identify other relevant papers including conference abstracts. In total, 9 case control studies (1041 patients), 6 case control studies (382 patients) and 7 studies (3403) were included examining the role of TP53 p.Arg72Pro variant in recurrent pregnancy loss, recurrent implantation failure and IVF outcome respectively. Combined genotype frequencies suggest that there may be an association between Pro/Pro genotype and recurrent pregnancy loss and Arg/Pro genotype and recurrent implantation failure. However, the association between TP53 p.Arg72Pro variant and recurrent pregnancy loss, recurrent implantation failure or IVF outcomes has not been clearly established. In conclusion, genotyping patients for the TP53 variant may enable us to identify an aetiology for patients experiencing unexplained recurrent pregnancy loss and detect individuals at risk of recurrent implantation failure before IVF treatment is initiated. Furthermore, exploring the mechanisms of action of the p53 protein may provide us with an insight into potential treatments.
Keywords
P53, Gene Polymorphism, Gene Variant, Recurrent Miscarriage, Recurrent Implantation Failure, IVF
To cite this article
Navneet Kaur, Mohamed Eltom, Karen Cheung, Siddharth Banka, Lamiya Mohiyiddeen, Role of P53 p.Arg72Pro Variant in Recurrent Pregnancy Loss, Recurrent Implantation Failure and IVF Outcome, International Journal of Genetics and Genomics. Vol. 8, No. 3, 2020, pp. 94-101. doi: 10.11648/j.ijgg.20200803.11
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
ASRM: The practice committee of American Society of Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertility and Sterility. 2013; 99 (1): 63.
[2]
Pandey MK, Rani R, Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet, 2005, 272 (2): 95-108.
[3]
Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T et al. Recurrent implantation failure: definition and management. Reproductive BioMedicine Online. 2014; 28 (1): 14-38.
[4]
Polanski L, Baumgarten M, Quenby S, Brosens J, Campbell B, Raine-Fenning N. What exactly do we mean by ‘recurrent implantation failure’? A systematic review and opinion. Reproductive BioMedicine Online. 2014; 28 (4): 409-423.
[5]
Coulam C, Clark D, Beer A, Kutteh W, Silver R, Kwak J et al. Current Clinical Options for Diagnosis and Treatment of Recurrent Spontaneous Abortion. American Journal of Reproductive Immunology. 1997; 38 (2): 57-74.
[6]
Daher S, Mattar R, Gueuvoghlanian-Silva B, Torloni M. Genetic Polymorphisms and Recurrent Spontaneous Abortions: An Overview of Current Knowledge. American Journal of Reproductive Immunology. 2012; 67 (4): 341-347.
[7]
Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002; 8: 463–81.
[8]
Choi H, Choi B, Lee S, Kim J, Cha K, Baek K. Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Molecular Reproduction and Development. 2003; 66 (1): 24-31.
[9]
Kolte A, Nielsen H, Moltke I, Degn B, Pedersen B, Sunde L et al. A genome-wide scan in affected sibling pairs with idiopathic recurrent miscarriage suggests genetic linkage. MHR: Basic science of reproductive medicine. 2011; 17 (6): 379-385.
[10]
Hu W, Feng Z, Atwal GS, Levine AJ. P53: a new player in reproduction. Cell Cycle. 2008 Apr 1; 7 (7): 848-52.
[11]
Tang W, Zhou X, Chan Y, Wu X, Luo Y. p53 codon 72 polymorphism and recurrent pregnancy loss: a meta-analysis. Journal of Assisted Reproduction and Genetics. 2011; 28 (10): 965-969.
[12]
Pflaum J, Schlosser S, Muller M. p53 Family and Cellular Stress Responses in Cancer. Frontiers in Oncology. 2014 Oct 21; 4: 285.
[13]
Su M, Lin S, Chen Y. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Human Reproduction Update. 2011; 17 (6): 803-812.
[14]
Kang H, Feng Z, Sun Y, Atwal G, Murphy M, Rebbeck T et al. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proceedings of the National Academy of Sciences. 2009; 106 (24): 9761-9766.
[15]
Sakamuro D, Sabbatini P, White E, Prendergast G. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene. 1997; 15 (8): 887-898.
[16]
Feng Z, Zhang C, Kang H, Sun Y, Wang H, Naqvi A et al. Regulation of female reproduction by p53 and its family members. The FASEB Journal. 2011; 25 (7): 2245-2255.
[17]
Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. International Journal of Cancer. 2003; 108 (2): 196-199.
[18]
Firouzibadi RD, Nasrin G, Maryam Ayazi R, Nasim T. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2009; 49 (2): 216-219.
[19]
Pietrowski D, Bettendorf H, Riener E, Keck C, Hefler L, Huber J et al. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Human Reproduction. 2005; 20 (4): 848-851.
[20]
Lledo B, Turienzo A, Ortiz J, Morales R, Ten J, Llácer J et al. Negative effect of P72 polymorphism on p53 gene in IVF outcome in patients with repeated implantation failure and pregnancy loss. Journal of Assisted Reproduction and Genetics. 2013; 31 (2): 169-172.
[21]
Yoon S, Choi Y, Kim J, Hong M, Lee S, Yang K et al. No association of p53 codon 72 polymorphism with idiopathic recurrent pregnancy loss in Korean population. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015; 192: 6-9.
[22]
Fraga L, Dutra C, Boquett J, Vianna F, Gonçalves R, Paskulin D et al. p53 signaling pathway polymorphisms associated to recurrent pregnancy loss. Molecular Biology Reports. 2014; 41 (3): 1871-1877.  done.
[23]
Kaare M, Butzow R, Ulander VM, Kaaia R, Aittomaki K, Painter JN. Study of p53 gene mutations and placental expression in recurrent miscarriage cases. Repod Biomed Online. 2009 Mar; 18 (3): 430-5. DOI: 10.1016/s1472-6483(10)60105-8.
[24]
Coulam CB, Kay C, Jeyendran RS. Role of p53 codon 72 polymorphism in recurrent pregnancy loss. Reprod Biomed Online. 2006 Mar; 12 (3): 378-82. DOI: 10.1016/s1472-6483(10)61013-9.
[25]
Oliveira JB, Vagnini L, Petersen CG, Mauri AL, Baruffi, Franco Jr JG. Is there an association between the TP53 codon 72 polymorphism genotype and recurrent miscarriage? Fertility and Sterility. 2013 Sept; 100 (3): S192-S193.
[26]
Franco Jr JG., Vagnini LD., Petersen CG., Mauri AL., Baruffi RLR., Oliveria JBA. Association of Single Nucleotide Polymorphisms with Recurrent Miscarriage. Fertility and Sterility. 2013. October: 100 (3): P550.
[27]
Kay, C., Jeyendran, R. and Coulam, C., 2006. p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reproductive BioMedicine Online, 13 (4), pp. 492-496. DOI: 10.1016/s1472-6483(10)60635-9.
[28]
Goodman, C., Jeyendran, R. and Coulam, C., 2009. P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure. Fertility and Sterility, 92 (2), pp. 494-498. DOI: 10.1016/j.fertnstert.2008.07.022.
[29]
Vagnini LD., Petersen CG., Mauri AL., Oliveira JB., Baruffi RLR., Franco Jr JG. A Prospective Evaluation of The Effect of Single Nucleotide Polymorphisms (SNPs) of Genes Involved In Human Reproduction on Recurrent Implantation Failure. Fertility and Sterility. 2013. October: 100 (3): P492.
[30]
Allanfan S., Nazarabadi MH., Enghelabifar M., Kayatzadeh J., Abdai KS., Jalali M., Moradi F., Musaviar N., Reza JZ., Mojarrad M. No Association Between Recurrent Implantation Failure Following In Vitro Fertilisation with Gene Polymorphism P53. Iranian Journal of Obstetrics, Gynaecology and Infertility. 18 (172) (pp 18-25), 2015.
[31]
Paskulin, D., Cunha-Filho, J., Souza, C., Bortolini, M., Hainaut, P. and Ashton-Prolla, P., 2012. TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure. Cell Death & Disease, 3 (9), pp. e392-e392. DOI: 10.1038/cddis.2012.116.
[32]
Patounakis, G., Treff, N., Tao, X., Lonczak, A., Scott, R. and Frattarelli, J., 2009. The p53 codon 72 single nucleotide polymorphism lacks a significant effect on implantation rate in fresh in vitro fertilization cycles: an analysis of 1,056 patients. Fertility and Sterility, 92 (4), pp. 1290-1296. DOI: 10.1016/j.fertnstert.2008.07.1783.
[33]
Ghorbian S., Mohammad Zadeh M., Nori M. Association between P53 PEX4 Polymorphism and IVF Outcome. European Journal of Human Genetics (2019) 26: 820–1023. https://doi.org/10.1038/s41431-018-0248-6.
[34]
Chan, Y., Zhu, B., Jiang, H., Zhang, J., Luo, Y. and Tang, W., 2016. Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome. PLOS ONE, 11 (11), p. e0167147. DOI: 10.1371/journal.pone.0167147.
[35]
Baruffi RLR, Petersen CG, Vagnini LD, Renzi A, Oliveira-Pelegrin GR, Mauri AL, Massaro FC, Cavagna M, Oliveira JBA, Franco Jr, JG. The tp53 codon 72 polymorphism (RS1042522) in women is not associated with pregnancy outcomes after ART. Fertility and Sterility. 2014 Sept; 102 (3 SUPPL. 1): e233.
[36]
Su, M., Lin, S. and Chen, Y., 2011. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Human Reproduction Update, 17 (6), pp. 803-812. DOI: 10.1093/humupd/dmr027.
[37]
Chen H, Yang X, Wang Z. Association between P53 Arg72Pro polymorphism and recurrent pregnancy loss: an updated systematic review and meta-analysis. Reprod Biomed Online. 2015 Aug; 31 (2): 149-53.
[38]
Zhang Y, Wu YY, Qiao FY, Zeng WJ. Association between P53 polymorphism at codon 72 and recurrent spontaneous abortion. J Huazhong Univ Sci Technolog Med Sci. 2016 Jun; 36 (3): 402-5.
[39]
Shi X., Xie X., Jia Y., Li S.. Maternal genetic polymorphisms and unexplained recurrent miscarriage: a systematic review and meta-analysis. Clin Genet 2017: 91: 265–284.
[40]
Wiwanitkit V. Null effect of p53 codon 72 polymorphism on recurrent pregnancy loss and recurrent implantation failure: A summative assessment. Indian J Hum Genet. 2011 Sep-Dec; 17 (3): 248–249.
[41]
Feng Y, Wu YY, Lin XJ, Yang L, Luo ZJ, Zhou YH, Chen J, Li N, Lin Z, Zhao X. Associations between the codon 72 polymorphism of the TP53 gene and the risk of recurrent implantation failure. J Obstet Gynaecol Res. 2016 Feb; 42 (2): 184-9.
[42]
Smeenk L, Lohrum M. Behind the scenes: unravelling the molecular mechanisms of p53 target gene selectivity (Review). Int J Oncol 2010: 37 (5): 1061–1070.
[43]
Dumont P, Leu JI, Della Pietra AC III, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357–365.
[44]
Hu W, Zheng T, Wang J. Regulation of Fertility by p53 Family Members. Genes Cancer. 2011 Apr; 2 (4): 420-430.
Browse journals by subject